v3.26.1
Equity Method Investments (Details) - USD ($)
2 Months Ended 3 Months Ended 12 Months Ended
Feb. 26, 2025
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Feb. 09, 2023
Equity Method Investment [Line Items]            
Equity method investments, net       $ 10,636,544  
Purchased interests       20,666,667    
Cash   $ 775,995   109,091 2,658,182  
Preferred stock, value        
Cost of investment           $ 19,460,000
Amortization expense   563,000 2,158,167    
Loss from equity method investment   392,677 392,677 (846,588)  
Distribution of earnings       1,745,000    
Intangible assets         8,725,712  
Goodwill   $ 12,808,197   $ 12,808,197  
Customer Relationships [Member]            
Equity Method Investment [Line Items]            
Estimated useful life       15 years    
Series B Stated Value [Member]            
Equity Method Investment [Line Items]            
Equity method investment payable       $ 666,667    
Laboratory Services MSO [Member]            
Equity Method Investment [Line Items]            
Ownership percentage 40.00%     40.00%    
Cash       $ 9,000,000    
Amortization expense $ 111,156       666,932  
Impairment loss         259,579  
Loss from equity method investment 503,833       79,923  
Distribution of earnings 0       611,888  
Series B Preferred Stock [Member]            
Equity Method Investment [Line Items]            
Equity method investments, net $ 11,000,000          
Preferred stock, value       $ 11,000,000  
Issuance shares (in Shares)       0 11,000  
Conversion price per share (in Dollars per share)       $ 56.7    
Series B Convertible Preferred Stock [Member]            
Equity Method Investment [Line Items]            
Equity method investments, net     $ 11,029,221      
Preferred stock, value       $ 1,000    
Conversion price per share (in Dollars per share)       $ 56.7    
Aggregate of common stock (in Shares)       194,004    
Avalon Lab [Member]            
Equity Method Investment [Line Items]            
Total ownership percentage 40.00%          
Avalon Lab [Member] | Series B Preferred Stock [Member]            
Equity Method Investment [Line Items]            
Preferred stock, value       $ 11,000,000    
Issuance shares (in Shares)       11,000    
Avalon Lab [Member] | Series B Stated Value [Member]            
Equity Method Investment [Line Items]            
Preferred stock, value       $ 1,000    
Unrelated Company [Member]            
Equity Method Investment [Line Items]            
Total ownership percentage 60.00%